Dr. Lau was recruited to UA in 2003 as director of the NIEHS P30 Core Center titled “Southwest Environmental Health Sciences Center” (SWEHSC). The mission of SWEHSC is to understand the mechanisms behind the modulation of human disease risk by environmental exposure. SWEHSC supports 4 Facility Cores that provide state-of-the-art technologies, including imaging, genomics, proteomics, bioinformatics and biostatistics support in various research areas. Dr. Lau and her research team utilize both genomics and proteomics approaches in studying diseases associated with environmental exposure. Prior to her current position, Dr. Lau spent 17 years in the Division of Pharmacology and Toxicology at the UT Austin, and served as the Director of the NIEHS-supported Toxicology Training Program. Dr. Lau's research focuses on three areas; (i) mechanisms of chemical-induced nephrotoxicity and nephrocarcinogenicity (ii) prostanoid and retinoid-mediated cytoprotection against ROS induced tissue injury, and (iii) proteomics approaches for the identification of chemical-induced protein post-translational modifications, and biomarker discovery for diseases such as diabetes, asthma and cancer. Dr. Lau collaborates extensively with basic and clinical scientists, integrating the basic sciences with translational opportunities in environmental health sciences research. Since 1987, Dr. Lau’s research has been funded by grants from the National Institutes of Health, National Science Foundation, the American Association of Colleges of Pharmacy, and the Pharmaceutical Manufacturers Association Foundation.